Literature DB >> 22627592

The shady side of dasatinib.

Alexander Zarbock1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22627592     DOI： 10.1182/blood-2012-03-418582

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  5 in total

1.  A phase I trial of KX2-391, a novel non-ATP competitive substrate-pocket- directed SRC inhibitor, in patients with advanced malignancies.

Authors:  Aung Naing; Roger Cohen; Grace K Dy; David S Hong; Lyn Dyster; David G Hangauer; Rudolf Kwan; Gerald Fetterly; Razelle Kurzrock; Alex A Adjei
Journal:  Invest New Drugs       Date:  2013-01-30       Impact factor: 3.850

Review 2.  Treatment recommendations for chronic myeloid leukemia.

Authors:  Michele Baccarani; Fausto Castagnetti; Gabriele Gugliotta; Francesca Palandri; Gianantonio Rosti
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-01-02       Impact factor: 2.576

3.  Src-dependent phosphorylation of μ-opioid receptor at Tyr336 modulates opiate withdrawal.

Authors:  Lei Zhang; Cherkaouia Kibaly; Yu-Jun Wang; Chi Xu; Kyu Young Song; Patrick W McGarrah; Horace H Loh; Jing-Gen Liu; Ping-Yee Law
Journal:  EMBO Mol Med       Date:  2017-11       Impact factor: 12.137

4.  Development of molecular and pharmacological switches for chimeric antigen receptor T cells.

Authors:  Bill X Wu; No-Joon Song; Brian P Riesenberg; Zihai Li
Journal:  Exp Hematol Oncol       Date:  2019-11-05

Review 5.  European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013.

Authors:  Michele Baccarani; Michael W Deininger; Gianantonio Rosti; Andreas Hochhaus; Simona Soverini; Jane F Apperley; Francisco Cervantes; Richard E Clark; Jorge E Cortes; François Guilhot; Henrik Hjorth-Hansen; Timothy P Hughes; Hagop M Kantarjian; Dong-Wook Kim; Richard A Larson; Jeffrey H Lipton; François-Xavier Mahon; Giovanni Martinelli; Jiri Mayer; Martin C Müller; Dietger Niederwieser; Fabrizio Pane; Jerald P Radich; Philippe Rousselot; Giuseppe Saglio; Susanne Saußele; Charles Schiffer; Richard Silver; Bengt Simonsson; Juan-Luis Steegmann; John M Goldman; Rüdiger Hehlmann
Journal:  Blood       Date:  2013-06-26       Impact factor: 22.113
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.